Professor Gill's team will be presenting 4 research papers in annual conference of ASIA PACIFIC DIGESTIVE DISEASE WEEK being held in Singapore in October 2011. Dear Prof Gill, We are pleased to inform you that your abstract (ID: APDW20110447 a0001) titled “EFFICACY OF TENOFOVIR (TDF) TREATMENT IN CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ADEFOVIR […]

Professor Gill's team will be presenting 4 research papers in annual conference of ASIA PACIFIC DIGESTIVE DISEASE WEEK being held in Singapore in October 2011. Dear Prof Gill, We are pleased to inform you that your abstract (ID: APDW20110447 a0001) titled “EFFICACY OF TENOFOVIR (TDF) TREATMENT IN CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO […]

World Hepatitis Day All over the world, the 19th of May is World Hepatitis Day. This is to make awareness among the people about hepatitis, its spread, prevention and treatment. Following are the comments of Prof. Dr. Muzzaffar Lateef Gill. Five hundred million people in the world population has exposure to hepatitis, Pakistan is no […]

Professor Gill's team will be presenting 4 research papers in "The 21st Conference of the Asian Pacific Association for the Study of the Liver (APASL 2011) 17-20 February 2011, QSNCC, Bangkok Thailand". i.e. Efficacy of Tenofovir (TDF) Treatment in Chronic Hepatitis B Patients with Suboptimal Response to Adefovir (ADV) More detail... Long Term Outcomes of […]

Professor Gill's team will be presenting 4 research papers in "The 21st Conference of the Asian Pacific Association for the Study of the Liver (APASL 2011) 17-20 February 2011, QSNCC, Bangkok Thailand" Professor Gill's team will be presenting 4 research papers in "The 21st Conference of the Asian Pacific Association for the Study of the Liver […]

Professor Gill\'S team will be presenting research work at EASL (european association of study of liver diseases) annual conference being held in Berlin Germany in April 2011 Our Reference: EASL2011_PO_ 305 Dear Muzaffar Gill, On behalf of the Scientific Programme Committee, we are very pleased to inform you that your abstract A-343-0024-00305 entitled: "VIROLOGICAL RELAPSE RATE […]

Professor Gill's team work will be presented in Barcelona , Spain in UEGW (United european gastroenterology week) October 23 to October 27th 2010 UEGW Barcelona 2010 October 23 - 27, 2010 Barcelona/Spain Dear Prof GILL,  Thank you for having submitted an abstract for "UEGW 2010" to be held in Barcelona this October.  Congratulations! Your abstract […]

Hepatitis C is a growing menace in our country. Early detection of the disease and timely intervention in terms of treatment is still the burning issue. Standard of care for treatment of chronic hepatitis C is weekly injection of Peg –interferon and Ribavirin.Its efficacy is 80% in our population. Unfortunately we are facing new challenges […]

Consensus interferon treatment for Pegylated interferon relapsers Hepatitis C patients rated the best study by Pakistan Society of Gastroenterology Annual conference in Bhurbun Muree May 30th 2010. OUTCOMES OF CONSESUS INTERFERON AND RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS WHO RELAPSED WITH PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN THERAPY. Authors: Uzma Adeeb ,Fatima Khattak […]

Consensus interferon treatment for Pegylated interferon relapsers Hepatitis C patients rated the best study by Pakistan Society of Gastroenterology Annual conference in Bhurbun Muree May 30th 2010.